126 related articles for article (PubMed ID: 9538156)
21. Sequence-specific transcriptional corepressor function for BRCA1 through a novel zinc finger protein, ZBRK1.
Zheng L; Pan H; Li S; Flesken-Nikitin A; Chen PL; Boyer TG; Lee WH
Mol Cell; 2000 Oct; 6(4):757-68. PubMed ID: 11090615
[TBL] [Abstract][Full Text] [Related]
22. Functional analysis of BRCA1 C-terminal missense mutations identified in breast and ovarian cancer families.
Vallon-Christersson J; Cayanan C; Haraldsson K; Loman N; Bergthorsson JT; Brøndum-Nielsen K; Gerdes AM; Møller P; Kristoffersson U; Olsson H; Borg A; Monteiro AN
Hum Mol Genet; 2001 Feb; 10(4):353-60. PubMed ID: 11157798
[TBL] [Abstract][Full Text] [Related]
23. Functional assay for BRCA1: mutagenesis of the COOH-terminal region reveals critical residues for transcription activation.
Hayes F; Cayanan C; Barillà D; Monteiro AN
Cancer Res; 2000 May; 60(9):2411-8. PubMed ID: 10811118
[TBL] [Abstract][Full Text] [Related]
24. Wild type PAX3 protein and the PAX3-FKHR fusion protein of alveolar rhabdomyosarcoma contain potent, structurally distinct transcriptional activation domains.
Bennicelli JL; Fredericks WJ; Wilson RB; Rauscher FJ; Barr FG
Oncogene; 1995 Jul; 11(1):119-30. PubMed ID: 7624119
[TBL] [Abstract][Full Text] [Related]
25. TFE3 contains two activation domains, one acidic and the other proline-rich, that synergistically activate transcription.
Artandi SE; Merrell K; Avitahl N; Wong KK; Calame K
Nucleic Acids Res; 1995 Oct; 23(19):3865-71. PubMed ID: 7479029
[TBL] [Abstract][Full Text] [Related]
26. Functional differences between the Oct2 transactivation domains determine the transactivation potential of individual Oct2 isoforms.
Annweiler A; Zwilling S; Wirth T
Nucleic Acids Res; 1994 Oct; 22(20):4250-8. PubMed ID: 7937153
[TBL] [Abstract][Full Text] [Related]
27. Identification of a RING protein that can interact in vivo with the BRCA1 gene product.
Wu LC; Wang ZW; Tsan JT; Spillman MA; Phung A; Xu XL; Yang MC; Hwang LY; Bowcock AM; Baer R
Nat Genet; 1996 Dec; 14(4):430-40. PubMed ID: 8944023
[TBL] [Abstract][Full Text] [Related]
28. BRCA1 physically and functionally interacts with ATF1.
Houvras Y; Benezra M; Zhang H; Manfredi JJ; Weber BL; Licht JD
J Biol Chem; 2000 Nov; 275(46):36230-7. PubMed ID: 10945975
[TBL] [Abstract][Full Text] [Related]
29. Rb-associated protein 46 (RbAp46) inhibits transcriptional transactivation mediated by BRCA1.
Chen GC; Guan LS; Yu JH; Li GC; Choi Kim HR; Wang ZY
Biochem Biophys Res Commun; 2001 Jun; 284(2):507-14. PubMed ID: 11394910
[TBL] [Abstract][Full Text] [Related]
30. Products of alternatively spliced transcripts of the Wilms' tumor suppressor gene, wt1, have altered DNA binding specificity and regulate transcription in different ways.
Wang ZY; Qiu QQ; Huang J; Gurrieri M; Deuel TF
Oncogene; 1995 Feb; 10(3):415-22. PubMed ID: 7845666
[TBL] [Abstract][Full Text] [Related]
31. BRCA1-induced large-scale chromatin unfolding and allele-specific effects of cancer-predisposing mutations.
Ye Q; Hu YF; Zhong H; Nye AC; Belmont AS; Li R
J Cell Biol; 2001 Dec; 155(6):911-21. PubMed ID: 11739404
[TBL] [Abstract][Full Text] [Related]
32. Creating a tool-kit for exploring BRCA1 function.
Parvin JD
Cancer Biol Ther; 2002; 1(5):509-10. PubMed ID: 12496478
[No Abstract] [Full Text] [Related]
33. BAP1: a novel ubiquitin hydrolase which binds to the BRCA1 RING finger and enhances BRCA1-mediated cell growth suppression.
Jensen DE; Proctor M; Marquis ST; Gardner HP; Ha SI; Chodosh LA; Ishov AM; Tommerup N; Vissing H; Sekido Y; Minna J; Borodovsky A; Schultz DC; Wilkinson KD; Maul GG; Barlev N; Berger SL; Prendergast GC; Rauscher FJ
Oncogene; 1998 Mar; 16(9):1097-112. PubMed ID: 9528852
[TBL] [Abstract][Full Text] [Related]
34. Functional domains of the heavy metal-responsive transcription regulator MTF-1.
Radtke F; Georgiev O; Müller HP; Brugnera E; Schaffner W
Nucleic Acids Res; 1995 Jun; 23(12):2277-86. PubMed ID: 7610056
[TBL] [Abstract][Full Text] [Related]
35. BRCA1 mediates ligand-independent transcriptional repression of the estrogen receptor.
Zheng L; Annab LA; Afshari CA; Lee WH; Boyer TG
Proc Natl Acad Sci U S A; 2001 Aug; 98(17):9587-92. PubMed ID: 11493692
[TBL] [Abstract][Full Text] [Related]
36. A new alternative splice variant of BRCA1 containing an additional in-frame exon.
Fortin J; Moisan AM; Dumont M; Leblanc G; Labrie Y; Durocher F; Bessette P; Bridge P; Chiquette J; Laframboise R; Lépine J; Lespérance B; Pichette R; Plante M; Provencher L; Voyer P; Simard J
Biochim Biophys Acta; 2005 Oct; 1731(1):57-65. PubMed ID: 16185777
[TBL] [Abstract][Full Text] [Related]
37. Basal components of the transcription apparatus (RNA polymerase II, TATA-binding protein) contain activation domains: is the repetitive C-terminal domain (CTD) of RNA polymerase II a "portable enhancer domain"?
Seipel K; Georgiev O; Gerber HP; Schaffner W
Mol Reprod Dev; 1994 Oct; 39(2):215-25. PubMed ID: 7826625
[TBL] [Abstract][Full Text] [Related]
38. Structural basis to characterise transactivation domain of BRCA1.
Yadav LR; Biswal MN; Hosur MV; Kumar NS; Varma AK
J Biomol Struct Dyn; 2017 Jan; 35(1):1-7. PubMed ID: 26727155
[TBL] [Abstract][Full Text] [Related]
39. Identification of an N-terminal transcriptional activation domain within Brn3b/POU4f2.
Martin SE; Mu X; Klein WH
Differentiation; 2005 Feb; 73(1):18-27. PubMed ID: 15733064
[TBL] [Abstract][Full Text] [Related]
40. BRCA1 interacts with dominant negative SWI/SNF enzymes without affecting homologous recombination or radiation-induced gene activation of p21 or Mdm2.
Hill DA; de la Serna IL; Veal TM; Imbalzano AN
J Cell Biochem; 2004 Apr; 91(5):987-98. PubMed ID: 15034933
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
